Continuity of Care and Long-Term Outcome Surveillance After Posterior Chamber Phakic IOL Implantation.

چکیده

Posterior chamber phakic intraocular lenses have a strong short-to-medium-term safety profile on the modern central-port platform, and a 2025 US Food and Drug Administration expansion of the indicated age range for a central-port phakic IOL to 21 to 60 years widens the eligible population. These…

متن کامل چکیده در سایت ناشر در دسترس است.